IL101602A0 - Anti-viral hybrid antibodies - Google Patents

Anti-viral hybrid antibodies

Info

Publication number: IL101602A0
Authority: IL; Israel
Prior art keywords: hybrid antibodies; viral hybrid; viral; antibodies; hybrid
Prior art date: 1991-04-18

Application number

IL101602A

Other versions

IL101602A (en

Original Assignee

Sinai School Medicine

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-04-18

Filing date

1992-04-16

Publication date

1992-12-30

1992-04-16 Application filed by Sinai School Medicine filed Critical Sinai School Medicine

1992-12-30 Publication of IL101602A0 publication Critical patent/IL101602A0/en

1996-10-31 Publication of IL101602A publication Critical patent/IL101602A/en

Links

230000000840 anti-viral effect Effects 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Virology (AREA)
Hematology (AREA)
Oncology (AREA)
AIDS & HIV (AREA)
Gastroenterology & Hepatology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

IL10160292A 1991-04-18 1992-04-16 Foreign peptide containing hybrid antibodies method for its preparation and compositions containing said foreign peptide IL101602A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US68737691A	1991-04-18	1991-04-18

Publications (2)

Publication Number	Publication Date
IL101602A0 true IL101602A0 (en)	1992-12-30
IL101602A IL101602A (en)	1996-10-31

Family

ID=24760226

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL10160292A IL101602A (en)	1991-04-18	1992-04-16	Foreign peptide containing hybrid antibodies method for its preparation and compositions containing said foreign peptide

Country Status (6)

Country	Link
EP (1)	EP0580758A4 (en)
JP (1)	JPH06506947A (en)
AU (1)	AU672580B2 (en)
CA (1)	CA2107329C (en)
IL (1)	IL101602A (en)
WO (1)	WO1992018540A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69023900T4 (en) *	1989-02-24	1996-10-02	Univ California	Genetically modified immunoglobulins.
US5969109A (en) *	1990-02-28	1999-10-19	Bona; Constantin	Chimeric antibodies comprising antigen binding sites and B and T cell epitopes
GB0102145D0 (en) *	2001-01-26	2001-03-14	Scancell Ltd	Substances

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0308936B1 (en) *	1987-09-23	1994-07-06	Bristol-Myers Squibb Company	Antibody heteroconjugates for the killing of HIV-infected cells
DE69324579T2 (en) *	1992-03-17	1999-09-23	Novartis Ag	GENETICALLY PRODUCED ANTIBODIES
ES2053413T3 (en) *	1992-05-14	1997-11-16	Polymun Scient Immunbio Forsch	PEPTIDES INDUCING ANTIBODIES THAT NEUTRALIZE GENETICALLY DIVERGENT HIV-1 ISOLATES.

1992
- 1992-04-10 WO PCT/US1992/002975 patent/WO1992018540A1/en not_active Application Discontinuation
- 1992-04-10 EP EP92911196A patent/EP0580758A4/en not_active Withdrawn
- 1992-04-10 CA CA002107329A patent/CA2107329C/en not_active Expired - Fee Related
- 1992-04-10 AU AU18919/92A patent/AU672580B2/en not_active Ceased
- 1992-04-10 JP JP4510879A patent/JPH06506947A/en active Pending
- 1992-04-16 IL IL10160292A patent/IL101602A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0580758A1 (en)	1994-02-02
AU1891992A (en)	1992-11-17
AU672580B2 (en)	1996-10-10
WO1992018540A1 (en)	1992-10-29
IL101602A (en)	1996-10-31
CA2107329C (en)	1999-04-27
EP0580758A4 (en)	1995-04-05
CA2107329A1 (en)	1992-10-19
JPH06506947A (en)	1994-08-04

Legal Events

Date	Code	Title
1997-03-18	FF	Patent granted
1998-10-30	KB	Patent renewed
2002-08-14	KB	Patent renewed
2006-12-27	MM9K	Patent not in force due to non-payment of renewal fees

Publication	Publication Date	Title
IL101602A0 (en)	1992-12-30	Anti-viral hybrid antibodies
AU344P (en)	1994-06-01	MEINOCHOT Rosa hybrid
AU293P (en)	1993-10-19	MEIGRONURISAR Rosa hybrid
AU288P (en)	1993-09-10	MEIDANCLAR Rosa hybrid
AU316P (en)	1994-03-22	KORSORB Rosa hybrid
AU324P (en)	1994-04-27	Auswhite Rosa hybrid
AU301P (en)	1993-11-01	SELFERR Rosa hybrid
AU194P (en)	1992-10-08	TANFUDERMOS Rosa hybrid
AU279P (en)	1993-09-01	MEIZOGREL Rosa hybrid
AU281P (en)	1993-09-01	LAVGLO Rosa hybrid
AU304P (en)	1993-11-01	SELALU Rosa hybrid
AU385P (en)	1994-09-09	MEINEBLE Rosa hybrid
AU404P (en)	1994-10-14	LAVJACK Rosa hybrid
AU384P (en)	1994-09-09	MEIFLOPAN Rosa hybrid
AU565P (en)	1996-06-13	Ausbord Rosa hybrid
AU294P (en)	1993-10-20	MEIPLATIN Rosa hybrid
AU297P (en)	1993-11-01	KORFERSE Rosa hybrid
AU300P (en)	1993-11-01	SELARGON Rosa hybrid
AU280P (en)	1993-09-01	MEISELGRA Rosa hybrid
AU305P (en)	1993-11-01	SELTITAAN Rosa hybrid
AU302P (en)	1993-11-01	SELSPRAY Rosa hybrid
AU303P (en)	1993-11-01	SELNESSEE Rosa hybrid
AU169P (en)	1992-06-18	MEIFRONY Rosa hybrid
AU105P (en)	1991-01-31	AROTRUSIM Rosa hybrid
AU326P (en)	1994-04-27	Auscot Rosa hybrid